{"id":"NCT00349336","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.","officialTitle":"A Randomized, Open Label Trial to Assess the Steady State Pharmacokinetics of Avastin Given With Either XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-08","primaryCompletion":"2008-11","completion":"2008-11","firstPosted":"2006-07-07","resultsPosted":"2010-02-26","lastUpdate":"2012-09-18"},"enrollment":64,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Colorectal Cancer"],"interventions":[{"type":"DRUG","name":"bevacizumab [Avastin]","otherNames":[]},{"type":"DRUG","name":"XELOX","otherNames":[]},{"type":"DRUG","name":"bevacizumab [Avastin]","otherNames":[]},{"type":"DRUG","name":"FOLFOX-4","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"This 2 arm study will compare the pharmacokinetics and safety of Avastin at steady state under 2 different dosing regimens, in combination with XELOX (oxaliplatin + Xeloda) or FOLFOX-4 (oxaliplatin, leucovorin and 5-fluorouracil). Patients randomized to the XELOX arm will receive Avastin (7.5mg/kg iv) on Day 1 of each 3 week cycle; patients randomized to the FOLFOX-4 arm will receive Avastin (5mg/kg iv) on Day 1 of each 2 week cycle. The anticipated time on study treatment is 3-12 months, and the target sample size is \\<100 individuals.","primaryOutcome":{"measure":"Weekly Steady-state Exposure of Bevacizumab","timeFrame":"Up to 48 weeks","effectByArm":[{"arm":"XELOX+Bevacizumab","deltaMin":4090.3,"sd":1047.6},{"arm":"FOLFOX-4+Bevacizumab","deltaMin":4022.4,"sd":1774.2}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":7,"countries":["Australia","Canada","New Zealand"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":32},"commonTop":["Fatigue","Diarrhoea","Nausea","Peripheral Sensory Neuropathy","Neuropathy Peripheral"]}}